Cargando…

Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis

BACKGROUND: As a first-line treatment regimen for Helicobacter pylori (H. pylori) infection, antibiotic therapy is widely used worldwide. However, the question of increasing antibiotic resistance must be considered. Given this issue, we need to find ways to reduce drug resistance. This study examine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Shu-Peng, Cheng, Qian, Feng, Cheng-Yang, Xu, Chan, Sun, Ming-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782940/ https://www.ncbi.nlm.nih.gov/pubmed/36569016 http://dx.doi.org/10.12998/wjcc.v10.i35.12959

Ejemplares similares

Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis
por: Xie, Ya-Lin, et al.
Publicado: (2020)

Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2018)

Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention
por: Corral, Juan E, et al.
Publicado: (2017)

Empirical versus tailored therapy based on genotypic resistance detection for Helicobacter pylori eradication: a systematic review and meta-analysis
por: Li, Meng, et al.
Publicado: (2023)

Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis
por: Wang, Zheyu, et al.
Publicado: (2022)

Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis
por: An, Ying, et al.
Publicado: (2018)

Association of Barrett’s esophagus with Helicobacter pylori infection: a meta-analysis
por: Ma, Shaoze, et al.
Publicado: (2022)

Meta-analysis of the correlation between Helicobacter pylori infection and autoimmune thyroid diseases
por: Hou, Yi, et al.
Publicado: (2017)

The endoscopic predictors of Helicobacter pylori status: a meta-analysis of diagnostic performance
por: Glover, Ben, et al.
Publicado: (2020)

The effect of Helicobacter pylori eradication on C-reactive protein: results from a meta-analysis
por: Watanabe, Jun, et al.
Publicado: (2021)

Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies
por: Zhou, Ben-Gang, et al.
Publicado: (2023)

Association between Helicobacter pylori and end-stage renal disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2017)

Is there an association between Helicobacter pylori infection and irritable bowel syndrome? A meta-analysis
por: Ng, Qin Xiang, et al.
Publicado: (2019)

Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis
por: Si, Xiao-Bei, et al.
Publicado: (2019)

Helicobacter pylori infection and peptic ulcer disease in cirrhotic patients: An updated meta-analysis
por: Wei, Lin, et al.
Publicado: (2021)

Is Helicobacter pylori Associated Functional Dyspepsia Correlated With Dysbiosis?
por: Kim, Yeon-Ji, et al.
Publicado: (2017)

Probiotics in 14-day triple therapy for Asian pediatric patients with Helicobacter pylori infection: a network meta-analysis
por: Wen, Juanjuan, et al.
Publicado: (2017)

Helicobacter pylori Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
por: Shi, Yan, et al.
Publicado: (2018)

Polymerase chain reaction-based tests for detecting Helicobacter pylori clarithromycin resistance in stool samples: A meta-analysis
por: Gong, Ren-Jie, et al.
Publicado: (2021)

Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of Helicobacter pylori infection: a systematic review and meta-analysis
por: Yao, Gaoyan, et al.
Publicado: (2023)

First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2019)

Antibiotic Resistance Conferred by Class 1 Integron in Vibrio Cholerae Strains: A Meta-analysis
por: Zuberi, Zavuga, et al.
Publicado: (2022)

Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Han, Yue, et al.
Publicado: (2021)

Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis
por: Ridouane, Yassine, et al.
Publicado: (2017)

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
por: Fong, Khi Yung, et al.
Publicado: (2022)

Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis
por: Citterio, Chiara, et al.
Publicado: (2018)

The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
por: Jang, Hyun Joo, et al.
Publicado: (2017)

Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
por: Cattrini, Carlo, et al.
Publicado: (2021)

The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis
por: Kim, Bum Jun, et al.
Publicado: (2017)

The efficacy and safety of first-line therapies for preventing chronic post-surgical pain: a network meta-analysis
por: Ning, Jie, et al.
Publicado: (2017)

Assessment of prophylactic antibiotics administration for acute pancreatitis: a meta-analysis of randomized controlled trials
por: Ding, Nan, et al.
Publicado: (2020)

First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis
por: Tao, Jiahao, et al.
Publicado: (2022)

Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis
por: Vogel, Arndt, et al.
Publicado: (2023)

Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%
por: Freemantle, Nick, et al.
Publicado: (2022)

Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis
por: Chen, Hao, et al.
Publicado: (2020)

High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of helicobacter pylori infection: A meta-analysis of randomized controlled trials
por: Zhang, Chong, et al.
Publicado: (2023)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori
por: Tamene, Yonas, et al.
Publicado: (2023)

Helicobacter pylori Infection Is Associated With Carotid Intima and Media Thickening: A Systematic Review and Meta‐Analysis
por: Simon, Orsolya Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1rs283l90tvv8ooaekuqh959t